#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-myelin-associated glycoprotein antibodies positive Leukaemia Soft tissue necrosis Mitochondrial encephalomyopathy Renal cancer metastatic Glomerulonephritis membranous Cortical dysplasia Osteosarcoma recurrent Squamous cell carcinoma of the vulva Hepatitis D Hairy cell leukaemia recurrent Hodgkin's disease refractory Inclusion body myositis Thrombotic microangiopathy Soft tissue sarcoma More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis Chordoma Acute respiratory distress syndrome – Life with Disease Myxofibrosarcoma – Treatment Proteus syndrome – Basic Information Mastocytosis Lymphangiosarcoma Nodal marginal zone B-cell lymphoma – Trials in Disease Shprintzen-Goldberg syndrome Waldenstrom’s macroglobulinaemia refractory – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Melatonin Betamethasone Acetate Azd7798 Ds-2325A Larotrectinib Sulfate Pilocarpine Hydrochloride Human Normal Immunoglobulin Pegenzileukin Davutamig Aup1602-C Cusatuzumab Bms-986315 GSKVX000000034798 Calcium Chloride OBI-821 Irinotecan Leflunomide Calcium Lactate Gluconate SGT-003 Encaleret Sulfate More therapies…

    Learn about Your Condition

    Post-traumatic stress disorder Bartonellosis Stress urinary incontinence Myelofibrosis Infertility male Factor VIII deficiency Carotid artery stenosis Pancoast's tumour Trisomy 21 Ewing's sarcoma Inflammation Normal pressure hydrocephalus Neonatal respiratory failure Vulvovaginal pruritus Anxiety More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on Bevacizumab and Dexamethasone for Treating Brain Radiation Damage in Patients with High-Grade Glioma or Brain Metastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Bevacizumab
    The Netherlands

  • Study of Gadobutrol for MRI in Adults with Cerebrospinal Fluid Disorders, Including Hydrocephalus and Brain Tumors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Central nervous system neoplasm
    • Cognitive disorder
    • Hydrocephalus
    Investigated Drugs:
    • Gadobutrol
    Norway

  • Study on the Effectiveness of Ublituximab and Drug Combination for Patients with Relapsing Multiple Sclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Cetirizine
    • Diphenhydramine
    • Gadobutrol
    Poland

  • Studying the Effects of Deferiprone on Motor Function in Children with Pelizaeus-Merzbacher Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pelizaeus-Merzbacher disease
    Investigated Drugs:
    • Deferiprone
    The Netherlands

  • Study on the Safety of Repeated Intra-Arterial Infusion of Mesenchymal Stem Cells for Children and Adolescents with Refractory Epilepsy

    Recruiting

    1 1 1
    Investigated Diseases:
    • Rasmussen encephalitis
    Investigated Drugs:
    • Allogenic Bone Marrow-Derived Mesenchymal Stem Cells Transduced With Icovir-5, Ex Vivo Expanded
    Spain

  • Study of Riluzole for Patients with Spinocerebellar Ataxia Type 7

    Recruiting

    2 1 1
    Investigated Drugs:
    • Riluzole
    Italy
Previous Page
1 … 25 26 27 28 29 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!